Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy
- PMID: 19434928
- PMCID: PMC3276835
- DOI: 10.1086/597069
Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy
Abstract
Bacille Calmette-Guérin (BCG) vaccination induces a marked increase in the interferon (IFN)-gamma response to Mycobacterium tuberculosis purified protein derivative (Mtb PPD) in UK adolescents, but not in Malawian adolescents. We hypothesized that Mtb PPD-induced IFN-gamma after BCG vaccination would be similar in infants from these 2 countries. Infants were vaccinated with BCG during the first 3-13 weeks of life. Three months after BCG vaccination, 51 (100%) of 51 UK infants had an IFN-gamma response to Mtb PPD, compared to 41 (53%) of 78 of Malawian infants, in whom responses varied according to their season of birth. We conclude that population differences in immune responses after BCG vaccination are observed among infants, as well as among young adults.
Figures
References
-
- World Health Organisation Bacille Calmette Guerin vaccine. Global estimates of BCG coverage. 2006 Bacille Calmette Guerin vaccine. Global estimates of BCG coverage (Accessed 3 February 2008)
-
- Department of Health Changes to the BCG vaccination programme in England. 2005
-
- Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995;346:1339–45. - PubMed
-
- Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993;22:1154–8. - PubMed
-
- Black GF, Weir RE, Floyd S, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002;359:1393–401. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
